Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://stevexwli060836.newsbloger.com/39660808/trelaglutide-exploring-a-new-option-for-chronic-diseases